In patients treated with PD-1 inhibitors, we failed to detect any significant increase in the expression of PD-1 with tumor progression, and, consequently, we speculate that although PD-1 inhibitors can effectively block PD-1 receptors on the surface of T cells, they may not necessarily effectively activate T cell function in these non-responder patients. Here, PDCD1 is linked to neoplasm.